Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01686373 · ClinicalTrials.gov registry record · Phase 2
Brain Stimulation and Aphasia Treatment
A Phase 2 study, sponsored by University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 74
- Enrollment target
NCT01686373 is a Phase 2 study that has completed, run by University of South Carolina. The registered enrollment target is 74 participants.
The verdict
NCT01686373, a Phase 2 study, has completed, sponsored by University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 74 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the changes in language processing of patients with chronic, post-stroke aphasia following the application of brain stimulation. The brain stimulation the investigators administer is called transcranial direct current stimulation (tDCS). It involves passing a weak electrical current through the brain between two electrodes in the form of damp sponges. One sponge will be placed over a specified area on the damaged left hemisphere, while the other sponge will be placed on the right scalp. Computer-controlled speech-language treatment will be administered during the application of tDCS.
Interventions
- DEVICE Activa Dose II Real tDCS
- DEVICE Activa Dose II Sham tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-04 |
| Est. Completion | 2017-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01686373
The ClinicalTrials.gov registry entry for NCT01686373 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Activa Dose II Real tDCS is the first listed.
NCT01686373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01686373 about?
NCT01686373 is a clinical study titled "Brain Stimulation and Aphasia Treatment". The purpose of this study is to assess the changes in language processing of patients with chronic, post-stroke aphasia following the application of brain stimulation. The brain stimulation the investigators administer is called transcranial direct current stimulation (tDCS). It involves passing a w...
What is the current status of trial NCT01686373?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 74 participants. The study started on 2012-04. Estimated completion is 2017-10.
What interventions are being tested in trial NCT01686373?
The interventions under investigation include: Activa Dose II Real tDCS (DEVICE), Activa Dose II Sham tDCS (DEVICE).
Who is sponsoring clinical trial NCT01686373?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.